AzTrials
AzTrials

Autism Spectrum DisorderNCT06011707

OPT-IN: Online Parent Training Intervention for Young Children Diagnosed With Autism Spectrum Disorder

A study testing OPT-IN in people with Autism Spectrum Disorder, run by Elizabeth Kelley.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observer-blinded randomized controlled clinical trial is to determine the effectiveness of a fully-online, parent-mediated, video-based, self-directed intervention for young children with autism (12-60 months) who have been diagnosed with autism in the last six months. Read more about this study

Who is it for?
Ages 12 to 60 months
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
OPT-IN
Could I receive a placebo?
No, everyone receives an active treatment
How many people
308 participants
Where
No sites listed yet
Study dates
30 Jun 2024to Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 60 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child diagnosed with Autism or Autism Spectrum Disorder within the last six months at baseline

Who cannot join

  • Parent does not speak English well enough to complete questionnaires
  • Parent or child has complete vision or hearing loss.
  • Parent or child is medically unstable.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Elizabeth A Kelley, PhD contact

613-533-2491

kelleyb@queensu.ca

About this study

Official title: OPT-IN: Online Parent Training Intervention for Young Children Diagnosed With Autism Spectrum Disorder: A Randomized Controlled Trial

The goal of this observer-blinded randomized controlled clinical trial is to determine the effectiveness of a fully-online, parent-mediated, video-based, self-directed intervention for young children with autism (12-60 months) who have been diagnosed with autism in the last six months. The main question[s] it aims to answer are:

  1. Does an online intervention for autistic children result in improved adaptive behaviour, compared to a psychoeducational control group?
  2. Does an online intervention for autistic children result in reduced autism symptoms in children, and decreased stress and increased self-efficacy in parents, compared to a psychoeducational control group?
  3. What are the predictors of response to intervention (i.e., child sex and age; initial autism symptoms and adaptive behavior; and parent self-efficacy, stress, and education).
Read more

Parents will be given six compulsory and eight optional online modules that will teach them skills to use while interacting with their autistic children to improve social and communication behaviours and minimize behaviours that interfere with learning.

The comparison group will receive six compulsory and eight optional online modules that will teach them about autism more broadly including diagnostic criteria, symptom profiles across development, etc.

Being tested
OPT-IN, Psychoeducational control
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OPT-INBehavioural

    Parents will be provided with online access to 6 compulsory video-based modules and 8 optional video-based modules. These modules will teach them about child development, behavioural principles, and naturalistic developmental intervention principles. These modules will promote skills that parents can use to increase their child's social and communication behaviours and minimize behaviours that interfere with learning (e.g., temper tantrums).

  • Psychoeducational controlOther

    This control intervention will provide parents with 6 compulsory and 8 optional modules that will teach them about autism and its developmental course.

Study groups in NCT06011707
Study groupRoleWhat they receive
OPT-IN interventionExperimentalNot described
Receives: Behavioral: OPT-IN
Psychoeducational controlActive comparatorNot described
Receives: Other: Psychoeducational control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Adaptive Behavior

    Change in Vineland Adaptive Behavior Scales, 3rd Edition Parent interview

    Measured: baseline, post-intervention (6 months past baseline), follow-up (6 months past post-intervention)

Secondary outcomes (4)
  1. Change in Autism Symptoms

    Change in Autism Impact Measure

    Measured: baseline, post-intervention (6 months past baseline), follow-up (6 months past post-intervention)

  2. Change in Parenting Stress

    Change in Parenting Stress Index, Short Form, version 4

    Measured: baseline, post-intervention (6 months past baseline), follow-up (6 months past post-intervention)

  3. Change in Parental Self-Efficacy

    Change in Early Intervention Parenting Self-Efficacy Scale

    Measured: baseline, post-intervention (6 months past baseline), follow-up (6 months past post-intervention)

  4. Change in Language

    Change in MacArthur-Bates Communicative Development Inventory

    Measured: baseline, post-intervention (6 months past baseline), follow-up (6 months past post-intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Aug 2023
  2. Study start30 Jun 2024 (estimated)
  3. Primary completionMar 2028 (estimated)
  4. Study completionMar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
308 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06011707
Sponsor's protocol ID
OPTIN
Status last verified
May 2024
First submitted
24 Apr 2023
Last updated
13 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be shared with other researchers through this website. The data will be de-identified by eliminating birthdate.

Questions about this trial

What is this clinical trial studying?

A study testing OPT-IN in people with Autism Spectrum Disorder, run by Elizabeth Kelley.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 May 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elizabeth A Kelley, PhD (613-533-2491, kelleyb@queensu.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Adaptive Behavior (time frame: baseline, post-intervention (6 months past baseline), follow-up (6 months past post-intervention)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in